| 000 | 01884 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516175544.0 | ||
| 264 | 0 | _c20131224 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1944-7884 | ||
| 024 | 7 |
_a10.1097/QAI.0b013e3182a99590 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodriguez, Benigno | |
| 245 | 0 | 0 |
_aSafety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial. _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes (1999) _cDec 2013 |
||
| 300 |
_a351-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aCD4-Positive T-Lymphocytes |
| 650 | 0 | 4 | _aCD8-Positive T-Lymphocytes |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Schedule |
| 650 | 0 | 4 | _aRNA, Viral |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 | _aViremia |
| 700 | 1 | _aAsmuth, David M | |
| 700 | 1 | _aMatining, Roy M | |
| 700 | 1 | _aSpritzler, John | |
| 700 | 1 | _aJacobson, Jeffrey M | |
| 700 | 1 | _aMailliard, Robbie B | |
| 700 | 1 | _aLi, Xiao-Dong | |
| 700 | 1 | _aMartinez, Ana I | |
| 700 | 1 | _aTenorio, Allan R | |
| 700 | 1 | _aLori, Franco | |
| 700 | 1 | _aLisziewicz, Julianna | |
| 700 | 1 | _aYesmin, Suria | |
| 700 | 1 | _aRinaldo, Charles R | |
| 700 | 1 | _aPollard, Richard B | |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 64 _gno. 4 _gp. 351-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAI.0b013e3182a99590 _zAvailable from publisher's website |
| 999 |
_c23210627 _d23210627 |
||